Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Mesenchymal Stem Cell-Derived Exosome Subpopulations Remained Consistent for 28 Culture Days, Displaying Therapeutic Effects in a Silicosis Mouse Model

May 2025 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Lung, Tissue Engineering

Developing An in Vitro Osteochondral Micro-Physiological System for Modeling Cartilage-Bone Crosstalk in Arthritis

May 2025 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Immunomodulation, Orthopedic, Tissue Engineering

Safety of Subconjunctival Injection of Mesenchymal Stromal Cells in Persistent Corneal Epithelial Disease – a Phase 1B Clinical Trial

May 2025 Bioprocessing, Cell Therapy, Clinical, Orthopedic

Developing a Novel Vascularized Bone Microdevice for Investigating The Post-Stroke Bone Microenvironment

May 2025 Bioprinting, Bioprocessing, Cardiovascular, Exosomes / Extracellular Vesicles, Immunomodulation, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Cold Storage Effects on Mitochondrial Bioenergetics and Protein Expression in Human Mesenchymal Stromal Cells

May 2025 Bioprocessing, Cell Therapy

Machine Learning Enabled Stem Cell Lipidomics

May 2025 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Immunomodulation, Tissue Engineering

Multi-niche Human Bone Marrow On-A-Chip for Studying The Interactions of Adoptive CAR-T Cell Therapies With Multiple Myeloma

May 2025 Bioprinting, Bioprocessing, Blood, Cancer, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering

Mesenchymal Stromal Cell Chondrogenic Differentiation Induced By Continuous Stiffness Gradient in Photocrosslinkable Hydrogels

May 2025 Bioprinting, Bioprocessing, MedTech, Devices, & Materials, Tissue Engineering

Tunable Hydrogel Networks By Varying Secondary Structures of Hydrophilic Peptoids Provide Viable 3D Cell Culture Platforms for hMSCs

May 2025 Bioprocessing, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation, MedTech, Devices, & Materials

Exosomes in Dermatology: Emerging Roles in Skin Health and Disease

May 2025 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Clinical, Dermal and Wound, Drug Screening, Exosomes / Extracellular Vesicles, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 … 29 30 31 32 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email